Purchase Order HHSF223201710414A

Award Date 8/23/17
Potential Completion Date 9/19/17
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $47,945 purchase order to Discovery Life Sciences, LLC for human primary hepatocytes, recovery, plating, and induction media. This firm fixed price contract supports the FDA's research and development efforts through the delivery of human liver cells and associated media. Discovery Life Sciences will perform the work in Huntsville, Alabama under the total small business set aside designation. No major...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Bioivt, LLC, a leading global provider of biological specimens and services. The contract, valued at $29,960, is for the acquisition of monkey and human (female) cryoplateable hepatocytes. The contract has an ultimate completion date of August 26, 2024. Bioivt, LLC is a prime contractor that has previously provided biological materials such as cryopreserved and cryoplateable hepatocytes, plasma, serum,...
This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
This is a federal contract awarded by the Defense Health Agency to Bioivt, LLC, a for-profit limited liability company that specializes in providing high-quality biological specimens and services for medical research. The contract, valued at $24,780.00, is for the delivery of male cynomolgus monkey hepatocytes. Bioivt has a history of providing biological materials, such as cryopreserved and cryoplateable hepatocytes, plasma, serum, urine, and surgical supplies, to support medical research...
This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Bioivt, LLC, a provider of biological specimens and services. The contract is for the delivery of 5 million units of male human cryoplateable hepatocytes, with a ceiling value of $75,000.00 and a period of performance ending on July 30, 2021. Bioivt has previously provided biological materials and services as a prime contractor and subcontractor to...

HUMAN PRIMARY HEPATOCYTES

Posted 8/23/17, 12:00 AM